Mach7 Technologies (M7T) Status update summary

Strategic reset and financial transformation

• Achieved positive operating cash flow in Q2 and Q3, maintaining zero debt and a strong balance sheet with A$18.5M cash.

• Cost base reduced by 6% through disciplined management and operational overhaul.

• Recurring revenue represents 85% of total revenue, reflecting a shift from lumpy capital deals to a predictable model.

• Leadership team revitalized, emphasizing cost discipline, commercial execution, and refreshed performance team.

• Growth now prioritized following a reset year focused on internal restructuring.

Vision, strategy, and outlook

• Aims to become the global imaging EMR by integrating patient images into electronic medical records and enhancing clinical workflows.

• Transitioning from archive to modular architecture, positioning imaging as a core patient record layer.

• Focus areas for FY27 include pipeline growth, sales momentum, improved delivery execution, partner leverage, leadership readiness, and cost efficiency.

• CTO appointment and refreshed performance team align with strategy and innovation goals.

• Fund growth from operating strength, maintaining cost discipline and staff engagement.

Market opportunity and industry trends

• Enterprise imaging market projected to double by 2030, reaching AUD 4 billion.

• Medical staff shortages and rising imaging volumes are accelerating adoption of AI and automation.

• Open APIs, EMR interoperability, and hybrid cloud/on-prem solutions are key industry trends.

• Security and compliance are critical, with healthcare organizations facing heightened cyber threats.

• Modular solutions allow customers to modernize without high-risk system replacements.